1. Introduction {#sec0005}
===============

The evolution rates of RNA viruses are amongst the highest of all organisms, making phylogenetic comparison between viral families often challenging. The *Nidovirales* order consists of four families that display broadly diverse features: from genome length spanning from 13 to 32 kb, to the set of encoded genes, or host range. Nonetheless, all nidoviruses share common characteristics such as the use of ribosomal frameshifting in order to translate a part of the nonstructural proteins, including the RNA-dependent RNA polymerase and the helicase. Moreover, they all code for a set of subgenomic (sg) mRNAs, and also for six essential enzyme/protein domains displaying the same linear organization along the genome: a 3C-like proteinase (3CLpro) flanked by 2 transmembrane domains (TM), then the RNA-dependent RNA polymerase (RdRp) and eventually a zinc-cluster binding domain (Zm) fused to a helicase belonging to superfamily 1 (HEL1). This specific protein organization can be summarized as follows: Nter-TM2-3CLpro-TM3-RdRp-(Zm)-HEL1-Cter.

The *Coronaviridae* together with the *Roniviridae* and the *Mesoniviridae* families are called "large-genome nidoviruses", because their genome length spans from 20 kb to 32 kb. In contrast, viruses of the fourth family, the *Arteriviridae*, belongs to the so-called "small-genome nidoviruses", since their genome length is between 13 and 16 kb ([@bib0155]).

Among *Nidovirales*, only some coronaviruses (CoVs) are known to infect humans. Human coronaviruses mostly cause mild respiratory infections. However, in 2003, a new coronavirus was identified to be responsible of a Severe Acute Respiratory Syndrome (SARS) ([@bib0345]). SARS-CoV eventually spread across the globe, causing a total of around 8400 infections and with a case/fatality rate (CFR) of 10%. Studies following the pandemic showed that SARS-CoV is a zoonotic virus jumping from bats to humans upon undefined critical mutational events, and possibly through palm civets as intermediate hosts ([@bib0235], [@bib0400]). Recently, the direct progenitor virus of SARS-CoV from bat has been isolated ([@bib0150]). This bat SARS-like CoV uses the human angiotensin converting enzyme II (ACE2) receptor and live viruses were recovered from Vero E6 cells ([@bib0150]). Hence, this virus does not require any mutations or intermediate hosts to infect human cells.

A decade after the SARS crisis, a new coronavirus was identified in the Middle East causing a form of pneumonia associated in some instances to kidney failure ([@bib0100], [@bib0415]). This coronavirus is now named Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and the epidemic is still ongoing two years after its discovery, counting at present (July 2014) 837 cases with the CFR of approximately 30%. MERS-CoV seems to be also of a zoonotic origin, as antibodies against MERS-CoV have been detected in camels ([@bib0285], [@bib0310]) and a case of camel-to-human transmission has been recently reported ([@bib0020]).

These two episodes confirm that few mutations allow zoonotic coronaviruses to jump the species barriers and threat human health worldwide. To date, no specific treatment against CoVs is available. A better understanding about how coronaviruses replicate in the host is therefore of critical importance to develop antiviral strategies aiming at controlling their spread and morbidity.

Coronavirus RNA replication and transcription are mediated by nonstructural proteins (nsps) encoded by two open reading frames, ORF1a and ORF1b ([Fig. 1](#fig0005){ref-type="fig"} ). These two ORFs are translated in a cap-dependent manner to yield two overlapping polyproteins referred as pp1a and pp1ab. ORF1b is translated only upon a ribosomal frameshift (−1) near the 3′ end of ORF1a, with ∼30% efficacy ([@bib0340]). Hence, the nsps encoded in ORF1b (nsp12 to nsp16) are expressed at lower levels compared to ORF1a-encoded products (nsp1 to nsp11). After polyprotein maturation mediated by viral proteases, these nsps associate to form a large replicative/transcription complex (RTC) with yet unknown cellular factors. The RTC not only entails the synthesis of new viral genomes from a full-length negative-stranded template, but also a nested set of so-called subgenomic (sg) mRNAs encoding structural and accessory proteins ([Fig. 1](#fig0005){ref-type="fig"}) ([@bib0280]). Coronavirus genome encodes for a total of 16 nsps, many having predicted and/or experimentally established function, and some others with yet defined functions.Fig. 1Coronavirus genome replication and transcription. The two open reading frames (ORFs) of the genomic mRNA are translated by a cap-dependent mechanism, yielding two polyproteins, pp1a and pp1ab, the latter requiring −1 ribosomal frameshifting (FS) near the 3′ end of ORF1a. Subsequently, the two polyproteins are cleaved by two or three ORF1a-encoded proteases to release a total of 16 nonstructural proteins (nsp1--nsp16). Then, they assemble with modified intracellular membranes ([@bib0210]) to form the replication/transcription complex (RTC). This huge RTC not only entails the synthesis of new genomes, but also produces a nested set of subgenomic (sg) mRNAs encoding structural and accessory proteins. The gray ball represents the cap structure. Nonstructural, structural and accessory genes are represented in blue, green and purple, respectively.

Among them, the RNA-dependent RNA polymerase (RdRp) encoded by nsp12 plays a central role in both RNA replication and transcription of the viral RNA. In general, RNA virus RdRps deal with genomes spanning from 5 to 15 kb in length. Coronavirus RdRps stand out as they not only replicate large RNA molecules (up to 32 kb) but also transcribe the nested set of sg mRNAs. Coronaviruses also possess other activities typically found in (+) RNA viruses, such as helicase and capping enzymes. On the other hand, less common or even unique RNA-processing activities are associated with other nsps, such as two nuclease activities: a 3′--5′ Exonuclease (ExoN) in the amino-terminal domain of nsp14 ([@bib0275]), and an endoribonuclease (NendoU) in nsp15 ([@bib0185]). While the role of the former begins to be well established in proofreading, the role of the latter is still unclear.

Coronaviruses also encode for another group of unique and interesting proteins: nsp7 to nsp10, which are all small proteins with no known protein homolog. Initially, they were all described as RNA binding proteins ([@bib0125], [@bib0360], [@bib0420]). In more recent works, three of them (nsp7, nsp8 and nsp10) were shown to act as activating co-factors of the polymerase (nsp7, nsp8), the 3′--5′ ExoN (nsp10) and the 2′O-methyltransferase (MTase) (nsp10) activities.

In this review, we present the current state of knowledge on SARS-CoV enzymes involved in RNA synthesis, proofreading, and capping.

2. Formation of the replicative/transcription complex (RTC) {#sec0010}
===========================================================

In coronaviruses, replication refers to viral genome amplification, while transcription refers to the synthesis of nested set of sg mRNAs. Both processes are mediated by the RTC, which is located in a membranous network, called reticulo-vesicular network, which arises from the rearrangements of endoplasmic reticulum (ER) membranes ([@bib0210]). Nsp3, through its transmembrane domain and together with two transmembrane proteins (nsp4 and nsp6) contribute to the anchoring of the RTC to membranes. It may be formed after viral replication cycles in order to hide replication intermediates (dsRNA) from innate immunity sensors ([@bib0210]).

3. The replication/transcription complex catalytic core {#sec0015}
=======================================================

As for all (+) RNA viruses, the replication catalytic core contains at least a helicase and an RNA-dependent RNA polymerase (RdRp).

3.1. The NTPase/helicase nsp13 {#sec0020}
------------------------------

A helicase domain of superfamily 1 helicases is harbored in SARS-CoV nsp13 C-terminal half ([@bib0190]). SARS-CoV nsp13 is able to unwind dsRNA (and dsDNA) in a 5′--3′ direction and required energy obtained from the hydrolysis of any NTPs and dNTPs ([@bib0190], [@bib0225], [@bib0375]). The N-terminal region of nsp13 contains a zinc-binding domain forms of 12 conserved cysteine and histidine residues. This domain is conserved in all nidoviruses and is critical for the human CoV-229E (HCoV-229E) helicase activity *in vitro* ([@bib0325]). In order to promote dsRNA unwinding, an RNA substrate of at least five nucleotides in length is required and an estimated unwinding rate of ∼280 base-pairs per second has been calculated, which is similar to other helicases ([@bib0005]). Interestingly, nsp13-mediated helicase activity has been reported to be stimulated 2-fold by nsp12 RdRp through direct protein/protein interaction ([@bib0005]).

3.2. Nsp12 RdRp and its cofactors nsp7 and nsp8: a processive polymerase complex {#sec0025}
--------------------------------------------------------------------------------

Nsp12 is an RNA-dependent RNA polymerase (RdRp) containing all conserved motifs (named with letters from A to F) of canonical RdRps ([@bib0290]). The polymerase active site (Ser-Asp-Asp within motif C) is conserved in all nidoviruses. Nsp12 also carries the motif G ([@bib0160]), which is a signature sequence of RdRps that initiate RNA synthesis in a primer-dependent manner ([@bib0380]). The *in vitro* nsp12 polymerase activity appeared weak and non processive ([@bib0065], [@bib0380]), at odds with the efficient replication of the very large RNA genome *in vivo*. Protein/protein interaction maps were established for SARS-CoV and among others, the nsp12/nsp8 interaction was recovered ([@bib0180]). The interaction between SARS-CoV nsp7 and nsp8 is also ascertained as they were co-crystallized and proposed to act as processivity factor for nsp12 ([@bib0420]).

In our lab, we tested this hypothesis and detected activation of the primer-dependent polymerase activity of nsp12 upon addition of nsp7 and nsp8 ([@bib0355]). This nsp7/nsp8/nsp12 complex is also able to synthesize RNA *de novo* in a processive fashion at least up to 340 nucleotides. To better understand how nsp7 and nsp8 activate and confer processivity to the RNA-synthesizing activity of nsp12, we used biochemical assays and a reverse genetics approach. We identified three amino acids in SARS-CoV nsp7 (K7, H36, and N37) that confer RNA-binding properties to the polymerase complex and that are also important for virus replication *in vivo*. Our study also pointed out three nsp8 residues (K58, P183, and R190) critical for SARS-CoV genome replication. The first one is involved in the interaction of the polymerase complex with RNA, while the two others are essential for nsp8/nsp12 interaction.

3.3. Nsp7 and nsp8, priming and/or processivity factors for nsp12? {#sec0030}
------------------------------------------------------------------

Nsp8 of SARS-CoV, feline CoV (FCoV) and HCoV-229E were previously shown to exhibit RNA polymerase activities ([@bib0475], [@bib0480], [@bib0410]). Moreover, the nsp8 N-terminal amino-acid composition appears to be important for this activity. Indeed, SARS-CoV nsp8 with an N-terminal His tag can synthesize only short oligonucleotides (\<6 nt) ([@bib0180]), while SARS-CoV and FCoV nsp8 without this tag are able to synthesize much longer RNA ([@bib0380], [@bib0410]). Upon addition of nsp7 to these "improved" recombinant nsp8, the RNA polymerase activity is stimulated ([@bib0380], [@bib0410]). Notably, the processing intermediates nsp7-nsp10 of HCoV-229E is also able to synthesize oligoribonucleotides ([@bib0410]).

Since nsp12 likely synthesizes RNA in a primer-dependent manner ([@bib0160]), nsp8 was proposed to act as a primase for nsp12. Moreover, SARS-CoV nsp8 crystal structure has been solved in complex with nsp7, showing a hexadecameric structure formed by eight molecules of nsp7 associated with eight nsp8 molecules ([@bib0420]). This structure is reminiscent of processivity factors such as the eukaryotic PCNA sliding clamp ([@bib0300]), and is able to accommodate a dsRNA in its central channel ([Fig. 2](#fig0010){ref-type="fig"}A) ([@bib0420]).Fig. 2Coronavirus nsp7/nsp8 structures. (A) Structure of the SARS-CoV nsp7/nsp8 hexadecamer supercomplex (from [@bib0420]; PDB 2AHM). To the left of this panel, SARS-CoV nsp7 and the two conformations of nsp8 are colored in orange, cyan and dark blue, respectively. To the right of this panel, the surface is colored according to electrostatic potential (blue, positive charge; red, negative charge). (B) Structure of the FCoV nsp7/nsp8 heterotrimer (left panel): two nsp7 molecules (in green) are associated to one molecule of nsp8 (in pink) (from [@bib0410]; PDB 3UBO). The right panel shows the surface colored according to electrostatic potential (blue, positive charge; red, negative charge). (C) C-terminal domain superimposition of the two SARS-CoV nsp8 forms (in cyan and dark blue) with FCoV nsp8 (in pink). The amino-terminal domain of nsp8 is very flexible, even in association with nsp7. Images were generated using PYMOL.

However, when the nsp8 primase was assayed in the context of the highly active polymerase complex (nsp7/nsp8/nsp12), no short RNAs could be detected ([@bib0355]). A hypothesis of this discrepancy could be that nsp8 in complex with nsp7 and nsp12 adopted a structural conformation that prevented the synthesis of short RNAs. In other words, nsp7/nsp8 may synthesize primers before associating with nsp12, or nsp7/nsp8-mediated primer synthesis may trigger the formation of the nsp7/nsp8/nsp12 polymerase complex. This possibility is to be examined in light of the tridimensional structure solved for nsp7 and nsp8 from FCoV ([@bib0410]). In this structure, FCoV nsp7 and nsp8 assemble into a heterotrimer formed by one nsp8 molecule associated to two nsp7 molecules, without any central channel ([Fig. 2](#fig0010){ref-type="fig"}B). SARS-CoV and FCoV nsp8 monomer folds are the same, except the conformation of the N-terminal helical domain that differs due to rotation over one or perhaps two hinge regions in the long alpha-helix, which undergoes partial unfolding at these hinge regions ([Fig. 2](#fig0010){ref-type="fig"}C) ([@bib0410], [@bib0420]).

Coronavirus nsp8 in association with nsp7 reveals a remarkable plasticity that may explain several functions triggered by the nature of their partnership and/or quaternary structure.

3.4. The puzzling nsp9 RNA-binding protein {#sec0035}
------------------------------------------

Nsp9 is a small (13 kDa in SARS-CoV) protein unique to coronavirus ([@bib0340]). The two available crystal structures of the protein ([@bib0125], [@bib0370]) reveal a novel fold made of an open six-stranded β-barrel and an additional α-helix that contains a GXXXG protein/protein interaction motif ([@bib0265]) involved in dimer formation. Noteworthy, this dimerization is critical for virus replication ([@bib0265]). In addition, SARS-CoV nsp9 binds ssRNA without sequence specificity ([@bib0125]), and has been shown to interact with nsp8 ([@bib0370]). The DNA replication catalytic core is formed, at least, by the association of a polymerase and its processivity factor, a helicase, and a single-strand DNA-binding protein (SSB). In the case of SARS-CoV, the first three actors were identified in nsp12, nsp8/nsp7 and nsp13, respectively. Regarding the nsp9 structural features, we can hypothesis that this protein may act as an SSB-like molecule thus protecting the CoV RNA genome from degradation during replication.

4. Is the 3′--5′ exonuclease nsp14 an RNA proofreading enzyme? {#sec0040}
==============================================================

The study of the coronavirus RNA repair machinery began with the discovery, by A.E. Gorbalenya and co-workers of nuclease motifs in ORF1b of the coronavirus genome. The discovery was published as part of the full analysis of the SARS-CoV genome ([@bib0340]). Amongst other RNA processing enzymes, the authors reported that nsp14 N-terminal domain is an RNA 3′--5′ exonuclease (ExoN) from the DEDD superfamily ([@bib0430]). They proposed the ExoN activity to be related to RNA proofreading, repair, and/or recombination. These hypotheses were based on DNA organisms, which have developed mechanisms for their large DNA genome biosynthesis and maintenance.

Ubiquitously spread in large-genome viruses, genes encoding homologs of coronavirus nsp14 ExoN are found in all nidoviruses (toro and roniviruses, with respectively 28 and 26 kb genomes), and mesoniviruses (a recently discovered related viral family with a 20 kb genome) ([@bib0425]). Small genome nidoviruses (arteriviruses, 13--15 kb) do not possess such ExoN activity (reviewed in, [@bib0155]). Outside nidoviruses, nsp14 ExoN homologs are rare, and have been solely identified in arenaviruses so far. In this last case, the ExoN activity is likely involved in counteracting the antiviral innate immunity ([@bib0165]).

The seminal discovery of the CoV 3′--5′ ExoN activity was followed by sequential findings confirming its validity and raised great interest in various fields such as evolution, drug design and drug resistance. The 3′--5′ ExoN enzyme activity was subsequently demonstrated at the enzyme level ([@bib0275]). The following most compelling demonstration was achieved by [@bib0120]. These authors showed that mutations in the DEDD motif, usually leading to the inactivation of the exonuclease activity, allowed recovering viable viruses that exhibit a 15--20-fold increase in replication errors. The study was conducted in MHV, a betacoronavirus-like SARS-CoV. Several significant complements and refinements of these studies appeared subsequently ([@bib0115]). Whereas less than one mutation per sequenced genome was observed for wild-type SARS-CoV (corresponding to an error frequency of 2 × 10^−5^), the SARS-CoV ExoN(−) showed 10 mutations per sequenced genome (error frequency = 3 × 10^−4^) ([@bib0115]). The same group recently showed that coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis ([@bib0335]). Indeed, they demonstrated that 5-fluorouracil (5FU) is incorporated into SARS-CoV and MHV RNA genomes, driving increased mutagenesis in ExoN(−) viruses ([@bib0335]). In addition, ribavirin, a guanosine analog, was also tested on a MHV ExoN(−) strain exhibiting up to 300-fold increased in sensitivity to this compound.

At the enzyme level, mechanistic studies showed that nsp14 ExoN activity is strongly enhanced (\>35-fold) by the addition of nsp10 ([@bib0050]). The nsp10/nsp14 ExoN complex was shown to be dsRNA-specific, but also able to excise one 3′ mismatched nucleotide mimicking a polymerase-mediated nucleotide misincorporation product ([@bib0050]). It is however unclear which enzyme state, nsp10/14 complex or nsp14 alone is involved in the aforementioned effects on RNA replication errors.

Evidences accumulate in favor of an RNA proofreading system *versus* a post-replicative mismatch repair. The latter generally involves a strand recognition system (*e.g.*, neosynthesized ssRNA methylation) to determine which nucleotide has to be corrected in a mismatch-bearing dsRNA. Then, a succession of enzymatic activities are required to replace the mismatched nucleotide: dsRNA endonucleolytic cleavage, RNA re-synthesis, and RNA ligation. Although several of these activities are embedded in the coronavirus ORF1ab, both strand recognition and ligase activities remain to be determined. In contrast, RNA proofreading generally involves a minimal set of activities of the polymerase dealing with the mismatched nucleotide and, a single 3′--5′ exonuclease activity vicinal to the active RNA polymerase.

To formally demonstrate the occurrence of RNA proofreading by nsp14, several questions have to be addressed, some of which have already been answered. First, nsp14 has to be made available to nsp12, and both should exhibit activities. This has been demonstrated in [@bib0355], with the association of nsp12 and nsp14 into an active complex. Second, the RNA mismatch clearance pathway should be reconstituted *in vitro*. That is, not only mismatch formation by nsp12 should be documented (nature and frequency), but also mismatch extension *vs* mismatch excision, yielding an estimate of the mismatch fixation into the RNA genome.

5. Coronavirus cap formation pathway {#sec0045}
====================================

Eukaryotic messenger RNA translation can be initiated by 2 different signals at the 5′-end, either by a cap structure or by a highly specific RNA tertiary structure named internal ribosome entry site (IRES).

Nidovirus genomes possess a cap structure at their 5′-end ([@bib0220], [@bib0385]). The cap is composed of a methylated guanosine at position N7 and linked to the first transcribed nucleotide of the RNA by a 5′--5′ triphosphate bridge, called "cap-0" (^7m^GpppN) ([Fig. 3](#fig0015){ref-type="fig"} ). A "cap-0" structure can then be converted into "cap-1" (^7m^Gppp~m2~N) by the addition of a methyl group to the 2′ position of the first RNA nucleotide ([@bib0145]) ([Fig. 3](#fig0015){ref-type="fig"}). The cap structure is then recognized by the eukaryotic initiation factor 4E (eIF4E), which, in association with other eIFs, recruit the small ribosomal subunit 40S (for review, [@bib0090]). Another cap function was described as protecting the mRNA from cellular 5′-3′ ExoN degradation ([@bib0135]). Recently, it has been shown that the 2′-O-methylation of the viral cap prevents viral genome recognition by the innate immune system of the host cell ([@bib0435]).Fig. 3Structure of 5′-end RNA cap. Cap structure is formed of a N7-methylated guanosine linked to the first RNA nucleotide *via* a 5′--5′ triphosphate bond. A second methyl group is added in 2′O position of the first nucleotide (for SARS-CoV, the first nucleotide is an adenosine).

Generally, cap formation requires three successive steps ([Fig. 4](#fig0020){ref-type="fig"} ) ([@bib0140]): (i) an RNA 5′-triphosphatase (RTPase) hydrolyses the 5′ γ-phosphate of the nascent mRNA; (ii) a guanylyltransferase (GTase) catalyses the transfer of a guanosine monophosphate (GMP) to the diphosphate mRNA 5′ end; (iii) an RNA methyltransferase (MTase) adds a methyl group at the N7 position of the cap guanine. As previously mentioned, CoV cap is a "cap-1", and thus another MTase transfers a methyl group to the 2′O position of the first mRNA nucleotide and this enzyme is so called 2′-O-MTase. As already mentioned, RNA cap methylation is a very important process, "hiding" the viral mRNA from innate immunity sensors but also preventing the pyrophosphorolytic reversal of the guanylyltransfer reaction ([@bib0135], [@bib0330]). Knocking-out cap methylation genes in SARS-CoV is lethal if not detrimental for virus replication ([@bib0015], [@bib0070]).Fig. 4SARS-CoV RNA capping pathway. SARS-CoV uses a canonical capping pathway. The 5′-end γ-phosphate of the RNA is hydrolyzed by the nsp13 RTPase activity. Then, the still unknown RNA GTase transfers a GMP to the 5′-diphosphate RNA end, forming a 5′--5′ triphosphate bond. Next, the nsp14 N7-MTase transfers a methyl group from the SAM donor to the N7-position of the cap, forming the "cap-0" structure. Lastly, the nsp16/nsp10 2′O-MTase methylates the first RNA nucleotide in the 2′O position, to form the "cap-1" structure.

SARS-CoV replicates in the cytoplasm, without access to the nuclear host-cell machinery for mRNA capping. Therefore, SARS-CoV has two options for capping its mRNAs: either the virus can hijack the cellular machinery or it has to produce its own RNA-capping enzymes ([@bib0255]). So far, out of the four necessary activities involved in mRNA capping, three were identified in the CoV ORF1b ([Fig. 1](#fig0005){ref-type="fig"}, [Fig. 4](#fig0020){ref-type="fig"}) ([@bib0350]). Current knowledge regarding the 4 steps of cap formation is more fully described in Sections [5.1](#sec0050){ref-type="sec"}, [5.2](#sec0055){ref-type="sec"}, [5.3](#sec0060){ref-type="sec"}, [5.4](#sec0065){ref-type="sec"}. Unless otherwise specified, all data were shown for the SARS-CoV.

5.1. The RNA 5′-triphosphatase (RTPase) {#sec0050}
---------------------------------------

RTPase catalyses the cleavage of the interphosphate bond between the β- and the γ-phosphates at the 5′-end of a triphosphorylated mRNA. Biochemical assays indicate that this function, together with a helicase activity might be played by nsp13 (as described in paragraph 3.1) ([@bib0190]). The combination of RTPase and helicase activities carried by the same protein has already been observed for many RNA viruses ([@bib0405], [@bib0035], [@bib0390], [@bib0240], [@bib0030]). Nevertheless, the exact RTPase mechanism as well as the high-resolution structure of nsp13 are still unknown.

5.2. The guanylyltransferase (GTase) {#sec0055}
------------------------------------

The guanylyltransferase (GTase) enzyme allows the transfer of GMP to the 5′-diphosphate mRNA end ([Fig. 4](#fig0020){ref-type="fig"}) ([@bib0315]). Most GTase proteins were shown to create covalent links with GMP before its subsequent transfer onto the diphosphate end of the RNA ([@bib0010]).

Many efforts have been made to identify the SARS-CoV GTase, unsuccessfully so far. No GMP covalent link was found for nsp7, nsp8, nsp10/nsp16, nsp12, nsp13, nsp14 or nsp15 ([@bib0195]). Yeast trans-complementation experiments, that had allowed discovery of the N7-MTase activity (see Section [5.3](#sec0060){ref-type="sec"}), did not allow the identification of the SARS-CoV GTase activity ([@bib0070]). This function remains elusive.

5.3. The N7-methyltransferase (N7-MTase) {#sec0060}
----------------------------------------

The methylation of the mRNA at the N7 position of the cap is the third step of cap formation and leads to a "cap-0" (^7m^GpppN) ([Fig. 3](#fig0015){ref-type="fig"}). N7-MTases are S-adenosyl-[l]{.smallcaps}-methionine (SAM) dependent enzymes. A methyl group is transferred from the SAM to the cap-RNA, producing also S-adenosyl-homocysteine (SAH) as by-product.

Functional screenings in yeast have revealed that SARS-CoV nsp14 is able to complement the deletion of the cellular cap N7-MTase ([@bib0070]). Furthermore, this activity was demonstrated by biochemical analysis. Nsp14 is able to methylate the N7 position in presence of SAM without any sequence specificity ([@bib0070], [@bib0045]). Indeed, nsp14 N7-MTase is active on different types of substrates: GTP and dGTP as well as cap analogs (GpppG, GpppA and ^m7^GpppG) ([@bib0195]). By sequence alignment and comparison of conserved motifs, the N7-MTase activity was attributed to the C-terminal domain of nsp14. Biochemical analysis revealed that both nsp14 enzymatic activities (ExoN and N7-MTase) are functionally distinct. However, based on deletion mutation analysis the two functional domains seem structurally linked ([@bib0070]) and a large region of nsp14 (aa 62 to 527) is essential for both N7-MTase and ExoN activities. The N7-MTase activity is strongly dependent on the N-terminal domain. However, the N-terminal ExoN domain is not involved in substrate binding for the N7-MTase activity ([@bib0080]). Nsp10, which was shown to strongly enhance the nsp14 ExoN activity ([@bib0050]), has no effect on the nsp14 N7-MTase activity ([@bib0045]).

The most conserved motif among N7-MTases is the SAM-binding site with a specific sequence signature "D/ExGxGxG" (where x refers to any amino acid) ([@bib0260]). According to CoV nsp14 sequence alignments, the motif DxGxPxG/A (aa 331 to 337) may represent the SAM-binding site of the nsp14 N7-MTase ([@bib0070], [@bib0045]). Moreover, two more regions, the first ranging from aa 310 to 428, overlapping with the core domain of N7-MTase, and the second ranging from aa 73 to 86, located at the N-terminus of the ExoN domain were found to be essential for nsp14 N7-MTase activity ([@bib0080]).

The SAM-dependent MTase family exhibits low sequence conservation but possesses a highly conserved structural fold, named Rossmann-like fold ([@bib0260], [@bib0320]). This fold is an alternation of β-stranded and α-helical regions, with 7 strands forming a central relatively planar β-sheet and a varying number of helices creating two layers, one on each side of the plane ([@bib0260]). Based on the known structure of mRNA cap N7-MTase, a structural model of SARS-CoV nsp14 core N7-MTase was created ([@bib0080]). This model confirmed the implication of DxGxPxG/A motif in SAM binding. Nevertheless, the determination of the full-length nsp14 structure is required to better understand the functional mechanism of the N7-MTase activity.

5.4. The 2′-O-methyltransferase (2′-O-MTase) {#sec0065}
--------------------------------------------

A 2′-O-MTase transfers a methyl group from the SAM methyl donor to the first mRNA nucleotide. This step converts the "cap-0" to a "cap-1" structure (^7m^Gppp~m2~N), this last form being found in all higher eukaryotes ([Fig. 3](#fig0015){ref-type="fig"}). Lower eukaryotes, including yeast, employ usually a "cap-0" (^7m^GpppN) structure. Many RNA viruses have evolved to adopt the "cap-1" structure, yielding to "cellular-like mRNA". [@bib0435] highlighted a biological role for viral mRNA 2′-O-methylation. They showed that 2′-O-methylation subverts the induction of type I interferon, acting as a molecular signature to distinguish self and non-self mRNA.

2′-O-MTases belong to the same family as N7-MTase, with low sequence identity but a common Rossmann-like structural fold (see section 5.3) encompassing the canonical catalytic tetrad K-D-K-E ([@bib0060], [@bib0130], [@bib0025]). The functional mechanism of the vaccinia virus (vv) 2′-O-MTase VP39 has been extensively described ([@bib0175], [@bib0245]). The reaction mechanism seems to involve a bi-molecular nucleophilic substitution (S~N~2 type) in which the nucleophilic ribose 2′-hydroxyl group of a lysine attacks the SAM methyl group, thus leading to the release of SAH ([@bib0230]).

Bioinformatics studies on the SARS-CoV have predicted a SAM-dependent 2′-O-MTase harbored by nsp16 ([@bib0395]). This activity was confirmed *in vitro* for FCoV nsp16 ([@bib0095]) and, with a lower activity for SARS-CoV nsp16. [@bib0045] showed evidences that SARS-CoV nsp16 2′-O-MTase activity is stimulated by the addition of nsp10 through direct protein/protein interaction. They found out that the nsp10/nsp16 complex can methylate the 2′O position of the first mRNA nucleotide only if the cap is already methylated at the N7 position. Using a mutational approach, K~46~-D~130~-K~170~-E~203~ residues were identified as the catalytic tetrad ([Fig. 5](#fig0025){ref-type="fig"} ). The 2′-O-MTase activity is completely abolished by any single mutation of this catalytic tetrad, demonstrating that although nsp10 stimulates the nsp16 2′-O-MTase activity, the catalytic site itself resides in nsp16 ([@bib0045]). Noteworthy, a similar activation of MTase activity was previously reported for the vaccinia virus capping enzyme ([@bib0255]). The structure of the co-factor nsp10 was first solved and revealed a novel fold with a pair of antiparallel N-terminal α-helices stacked against an irregular β-sheet, a coil-rich C-terminus and two Zn fingers ([@bib0205], [@bib0360]). The crystal structure of SARS-CoV nsp16 in complex with nsp10 was determined in 2011 by 2 groups ([Fig. 5](#fig0025){ref-type="fig"}) ([@bib0075], [@bib0085]). The nsp10 overall structure in complex with nsp16 remains quite similar to the one determined for the free nsp10. Nsp16 adopts a canonical SAM-dependent MTase fold with two binding domains, one for the methyl donor SAM and another for the methyl acceptor substrate (capped-RNA). Nsp16 fold is a central β-sheet of 7 strands surrounded by five α-helices. Compared to the MTase canonical fold, two α-helices are absent in the SAM binding region of nsp16, but the complex formed with nsp10 seems to compensate and stabilize the overall structure of nsp16. Whereas earlier reports claimed that Mg^2+^ was necessary for the nsp10/nsp16 2′-O-MTase activity ([@bib0045]), no cation was observed in the active site. However, the structure shows a Mg^2+^ located far from the SAM-binding site ([Fig. 5](#fig0025){ref-type="fig"}). It is thus possible that divalent cations play a structural role in the nsp16 structure in stabilizing the general fold. The organization of the active site is in agreement with the current 2′-O-MTase mechanism described above, transferring the methyl group of SAM to capped-RNA. Although no RNA-bound structure is available to date, a putative RNA-binding groove was proposed based on the highly positively charged patch found on nsp16 at the proximity of the catalytic site ([Fig. 6](#fig0030){ref-type="fig"} ) ([@bib0075], [@bib0085]).Fig. 5Crystal structure of SARS-CoV nsp10/nsp16 complex. Ribbon representation of nsp10 (in gray) in complex with nsp16 (in yellow) (from [@bib0085]; PDB 2XYQ). Mg^2+^ ion (in brown) found on nsp16 is localized at the opposite side of the 2′O-MTase active site which is formed by the catalytic tetrad K46, D130, K170 and E203 (in pink). The by-product of the reaction, SAH in cyan is localized near the catalytic site. The two Zn^2+^ ions (orange) on nsp10 are not involved in the interaction with nsp16.Fig. 6Sinefungin binding site and hypothetical RNA binding groove on SARS-CoV nsp16. Electrostatic potential surface of nsp16 presented with SAH (in cyan) and sinefungin (in yellow), which are localized in the same pocket. A putative binding groove for a capped-mRNA is indicated.*Source*: From [@bib0085] and [@bib0075]; PDB codes 2XYQ and 2XYV.

Nsp10 alone does not exhibit any enzyme activity but appears to be central for two distinct regulatory mechanisms (nsp14 ExoN and nsp16 2′-O-MTase). Our group has determined the interaction surface of nsp10 with nsp14 and with nsp16 ([@bib0055], [@bib0250]). These studies show that the same nsp10 interface is involved in complex formation with both nsp16 and nsp14. However, in the case of nsp10/nsp14, the interaction interface is substantially wider ([Fig. 7](#fig0035){ref-type="fig"} ). As a consequence, nsp10 cannot interact simultaneously with both nsp14 and nsp16. Nevertheless, the two regulatory functions of nsp10 may still act simultaneously, since nsp10 is translated in stoichiometric excess compared to ORF1b-encoded nsp14 and nsp16 ([Fig. 1](#fig0005){ref-type="fig"}) ([@bib0340]).Fig. 7Comparison of SARS-CoV nsp10 interaction surface with nsp14 and with nsp16. The SARS-CoV nsp10/nsp16 complex structure is presented with nsp10 solvent-accessible surface in gray, and nsp16 in yellow ribbon. Nsp10 residues involved in the interaction with nsp14 are depicted in green. The interaction surface of nsp10 with nsp16 and nsp14 overlaps, the latter being wider ([@bib0055]).

Eukaryotic and viral mRNA capping systems show many differences ([@bib0145]), and given the essential role fulfilled by these systems, each protein involved in this process should be considered as a potential antiviral target. In particular, viral MTases seem to be good candidates ([@bib0110], [@bib0040], [@bib0105]). Indeed, mutations abolishing MTase activities have a detrimental effect on viral replication ([@bib0015], [@bib0305], [@bib0070]). *In vitro*, sinefungin and SAH (the by-product of the methyl transfer reaction) were found to inhibit both SARS-CoV MTase activities ([@bib0045]). Furthermore, a crystal structure of the SARS-CoV nsp10/nsp16 complex with sinefungin was solved and revealed that the molecule is bound in the SAM-binding pocket and hence should inhibit nsp16 2′-O-MTase activity ([Fig. 6](#fig0030){ref-type="fig"}). In addition, aurintricarboxylic acid (ATA), expected to bind MTase active site, inhibits SARS-CoV replication ([@bib0170], [@bib0270]). Biochemical assays demonstrated that ATA inhibits both nsp14 N7-MTase and nsp16 2′-O-MTase activities ([@bib0045]). Recently, [@bib0365] developed a yeast-based high-throughput antiviral screening system to find novel anti-coronavirus drugs. This study confirmed that sinefungin significantly suppresses the growth of yeast cells complemented with nsp14 N7-MTase gene. However, sinefungin is not a specific inhibitor as it also inhibits yeast and human MTases ([@bib0365]).

6. Conclusion {#sec0070}
=============

Coronaviruses have only recently attracted a wider audience due to public health issues generated by SARS- and MERS-CoV emergences. However, remarkable achievements have been made regarding the elucidation of structures, functions, and mechanisms of what appears to be the most sophisticated and regulated (+) RNA genome replication/transcription machinery so far. Although other viruses, such as Hepatitis C and Influenza viruses, might be better and sooner controlled through antiviral therapies, the study of coronaviruses may well accelerate our current understanding of RNA synthesis, evolution, capping, repair, as well as all novel implications arising from the combination and coordination of these RNA processing activities. Further experiments should open an entirely new field of research, since for viral RNA synthesis, very few data are available on these processes. For example, it is possible to quantitate mismatch formation for some RNA viruses (Hepatitis C Virus ([@bib0295]), Poliovirus ([@bib0215]), Dengue virus ([@bib0200])) and sometimes only for a restricted set of nucleotides (Dengue virus ([@bib0200])).

The progress made on SARS-CoV RNA synthesis machinery comprehension will soon allow to measure, through genome sequencing, the RNA replication fidelity. This knowledge will likely open a Pandora box containing the coronavirus "playbook" exposing how they maintain the integrity of their large genomes, while generating the population diversity required for emergence and adaptation. Knowing in detail these mechanisms will provide new antiviral strategies.
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